THE COST-EFFECTIVENESS AND COST-UTILITY OF PALIPERIDONE PALMITATE IN THE TREATMENT OF SCHIZOPHRENIA IN GUATEMALA

被引：1
|
作者：
Obando, C. A. [1 ]
Gonzalez, L. [2 ]
Muschett, D. [1 ]
机构：
[1] Janssen, Panama City, Panama
[2] Janssen, Raritan, NJ USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.2089
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A695 / A695
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF TRITACE COMB (RAMIPRIL/HCTZ) IN TREATMENT OF HYPERTENSION IN POLAND
    Kawalec, P.
    Lis, J.
    Glasek, M.
    VALUE IN HEALTH, 2008, 11 (06) : A391 - A392
  • [42] THE COST-EFFECTIVENESS OF PALIPERIDONE ER IN ACUTE PHASE OF SCHIZOPHRENIA IN TURKEY
    Kanbur, B.
    Karamustafalioglu, O.
    Dilbaz, N.
    Turkcan, S.
    Sarioz, F.
    Tatar, F.
    VALUE IN HEALTH, 2008, 11 (06) : A584 - A584
  • [43] Influenza treatment with neuraminidase inhibitors: Cost-effectiveness and cost-utility in healthy adults in the United Kingdom
    Sander B.
    Gyldmark M.
    Hayden F.G.
    Morris J.
    Mueller E.
    Bergemann R.
    The European Journal of Health Economics, 2005, 6 (3) : 244 - 252
  • [44] A COST-EFFECTIVENESS ANALYSIS OF THE LONG-ACTING ANTISPYCHOTIC DRUGS PALIPERIDONE PALMITATE, OLANZAPINE PAMOATE AND RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA IN FINLAND
    Einarson, T. R.
    Pudas, H.
    Zilbershtein, R.
    Jensen, R.
    Nielsen, A. T.
    Piwko, C.
    Hemels, M.
    Vincente, C.
    VALUE IN HEALTH, 2012, 15 (07) : A337 - A338
  • [45] Cost-effectiveness analysis of aripiprazole once-monthly versus paliperidone palmitate once-monthly in the treatment of schizophrenia in France
    Gozlan, G.
    Lecardeur, L.
    Monfort, A-S
    Doz, M.
    Ortiz, I
    Larroumets, P.
    Lafuma, A.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2018, 44 (06): : 496 - 503
  • [46] COST-UTILITY ANALYSIS OF INJECTABLE PALIPERIDONE PALMITATE 3-MONTH FORMULATION VERSUS INJECTABLE RISPERIDONE AND ORAL ANTIPSYCHOTICS FOR THE TREATMENT OF SCHIZOPHRENIA IN COLOMBIA
    Amezquita, M.
    Alzate, M.
    Cordoba, R.
    Oviedo, G.
    Lopez-Jaramillo, C.
    Guerrero, E.
    Aguirre, A.
    VALUE IN HEALTH, 2018, 21 : S185 - S185
  • [47] Cost-utility analysis in schizophrenia
    Awad, AG
    Voruganti, LP
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 : 22 - 28
  • [48] The cost-effectiveness of oral health interventions: A systematic review of cost-utility analyses
    Hettiarachchi, Ruvini M.
    Kularatna, Sanjeewa
    Downes, Martin J.
    Byrnes, Joshua
    Kroon, Jeroen
    Lalloo, Ratilal
    Johnson, Newell W.
    Scuffham, Paul A.
    COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 2018, 46 (02) : 118 - 124
  • [49] Cost-effectiveness and cost-utility of long-term management strategies for heartburn
    Goeree, R
    O'Brien, BJ
    Blackhouse, G
    Marshall, J
    Briggs, A
    Lad, R
    VALUE IN HEALTH, 2002, 5 (04) : 312 - 328
  • [50] Health Economic Studies An Introduction to Cost-benefit, Cost-effectiveness, and Cost-utility Analyses
    Angevine, Peter D.
    Berven, Sigurd
    SPINE, 2014, 39 (22S) : S9 - S15
12345